Trial Profile

Phase IIb trial of obeticholic acid in patients with secondary bile acid diarrhoea (sBAD) due to Crohn's disease

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 30 Jan 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Obeticholic acid (Primary)
Indications Crohn's disease; Diarrhoea
Focus Therapeutic Use

Most Recent Events

30 Jan 2014 New trial record
09 Jan 2014 Intercept Pharmaceuticals expects to initiate this trial in the second half of 2014, according to a media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com